Under-Reporting of Patient-Reported Outcome in Hematological Malignancies Trials by Vidal, Liat, Messina, Anthony J, Vidal, Laura, Andrianov, Vasily, Curtis, Kelly K., Moss, Keren R.

Get full text

Under Reporting of Patient Reported Outcomes (PROs) in Myeloproliferative Neoplasm (MPN) Clinical Trials by Messina, Anthony J, O'Brien, Quentin E, Andrianov, Vasily, Moss, Keren R., Vidal, Laura, Vidal-Fisher, Liat

Get full text

Under-Reporting of Patient Reported Outcome (PRO) in Clinical Trials by Vidal-Fisher, Liat, Curtis, Kelly K., Vidal, Laura, Moss, Keren R.

Get full text

Abstract A088: Evolution of the use of nonrandomized (NRCT) versus randomized (RCT) phase 2 trial designs preceding phase 3 registration trials for oncology drugs approved from 200... by Curtis, Kelly K., Vidal Boixader, Laura, Palatka, Jozsef, Vidal, Liat, Kenny, Nicholas, Moss, Keren R.

Get full text

Delineating the expanding phenotype associated with SCAPER gene mutation by Fasham, James, Arno, Gavin, Lin, Siying, Xu, Mingchu, Carss, Keren J., Hull, Sarah, Lane, Amelia, Robson, Anthony G., Wenger, Olivia, Self, Jay E., Harlalka, Gaurav V., Salter, Claire G., Schema, Lynn, Moss, Timothy J., Cheetham, Michael E., Moore, Anthony T., Raymond, F. Lucy, Chen, Rui, Baple, Emma L., Webster, Andrew R., Crosby, Andrew H.

Get full text

Delineating the expanding phenotype associated with SCAPER gene mutation by Fasham, James, Arno, Gavin, Lin, Siying, Xu, Mingchu, Carss, Keren J, Hull, Sarah, Lane, Amelia, Robson, Anthony G, Wenger, Olivia, Self, Jay E, Harlalka, Gaurav V, Salter, Claire G, Schema, Lynn, Moss, Timothy J, Cheetham, Michael E, Moore, Anthony T, Raymond, F Lucy, Chen, Rui, Baple, Emma L, Webster, Andrew R, Crosby, Andrew H

Get full text